ALLOSTERIC MODULATION OF LIGAND-BINDING TO [H-3] (+)PENTAZOCINE-DEFINED SIGMA-RECOGNITION SITES BY PHENYTOIN

被引:36
作者
DEHAVENHUDKINS, DL [1 ]
FORDRICE, FY [1 ]
ALLEN, JT [1 ]
HUDKINS, RL [1 ]
机构
[1] ALBANY MOLEC RES,ALBANY,NY 12203
关键词
D O I
10.1016/0024-3205(93)90609-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The allosteric modulation of sigma recognition sites by phenytoin (diphenylhydantoin) has been demonstrated by the ability of phenytoin to stimulate binding of various [H-3]sigma ligands, as well as to slow dissociation from sigma sites and to shift sigma sites from a low- to a high-affinity state. Phenytoin stimulated the binding of the sigma1-selective ligand [H-3](+)pentazocine in a dose-dependent manner. Stimulation of binding at a final concentration of 250 muM phenytoin was associated with a decrease in the K(D). The affinities of the sigma reference compounds caramiphen, dextromethorphan, dextrorphan, (+)3-PPP and (+)SKF-10,047 were three- to eight-fold higher, while the affinities of benzetimide, BMY-14802, carbetapentane, DTG and haloperidol were unchanged in the presence of 250 muM phenytoin. The relative sensitivity of sigma compounds to allosteric modulation by phenytoin is not a property of all sigma ligands, and may provide an in vitro basis for distinguishing actions of sigma compounds and predicting sigma effects in vivo.
引用
收藏
页码:41 / 48
页数:8
相关论文
共 32 条
[1]  
ALLEN J T, 1991, Society for Neuroscience Abstracts, V17, P1256
[2]   SIGMA-RECEPTORS NEGATIVELY MODULATE AGONIST-STIMULATED PHOSPHOINOSITIDE METABOLISM IN RAT-BRAIN [J].
BOWEN, WD ;
KIRSCHNER, BN ;
NEWMAN, AH ;
RICE, KC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 149 (03) :399-400
[3]  
CALDERON S N, 1990, Society for Neuroscience Abstracts, V16, P784
[4]   ENANTIOMERIC N-SUBSTITUTED N-NORMETAZOCINES - A COMPARATIVE-STUDY OF AFFINITIES AT SIGMA, PCP, AND MU OPIOID RECEPTORS [J].
CARROLL, FI ;
ABRAHAM, P ;
PARHAM, K ;
BAI, X ;
ZHANG, X ;
BRINE, GA ;
MASCARELLA, SW ;
MARTIN, BR ;
MAY, EL ;
SAUSS, C ;
DIPAOLO, L ;
WALLACE, P ;
WALKER, JM ;
BOWEN, WD .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (15) :2812-2818
[5]  
CRAVISO GL, 1983, MOL PHARMACOL, V23, P629
[6]   BINDING OF DEXETIMIDE AND LEVETIMIDE TO [3H](+)PENTAZOCINE-DEFINED AND [3H]1,3-DI(2-TOLYL)GUANIDINE-DEFINED SIGMA-RECOGNITION SITES [J].
DEHAVENHUDKINS, DL ;
HUDKINS, RL .
LIFE SCIENCES, 1991, 49 (18) :PL135-PL139
[7]   COMPETITIVE INTERACTIONS AT [H-3] 1,3-DI(2-TOLYL)GUANIDINE (DTG)-DEFINED SIGMA-RECOGNITION SITES IN GUINEA-PIG BRAIN [J].
DEHAVENHUDKINS, DL ;
FLEISSNER, LC .
LIFE SCIENCES, 1992, 50 (09) :PL65-PL70
[8]   LACK OF CORRELATION BETWEEN SIGMA-BINDING POTENCY AND INHIBITION OF CONTRACTIONS IN THE MOUSE VAS-DEFERENS PREPARATION [J].
DEHAVENHUDKINS, DL ;
HILDEBRAND, LM ;
FLEISSNER, LC ;
WARD, SJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 203 (03) :329-335
[9]   A SIGMA-LIKE BINDING-SITE IN RAT PHEOCHROMOCYTOMA (PC12) CELLS - DECREASED AFFINITY FOR (+)-BENZOMORPHANS AND LOWER MOLECULAR-WEIGHT SUGGEST A DIFFERENT SIGMA RECEPTOR FORM FROM THAT OF GUINEA-PIG BRAIN [J].
HELLEWELL, SB ;
BOWEN, WD .
BRAIN RESEARCH, 1990, 527 (02) :244-253
[10]   LACK OF FUNCTIONAL EVIDENCE FOR THE INVOLVEMENT OF SIGMA-OPIATE RECEPTORS IN THE ACTIONS OF THE 3-PPP ENANTIOMERS ON CENTRAL DOPAMINERGIC SYSTEMS - DISCREPANCIES BETWEEN INVITRO AND INVIVO OBSERVATIONS [J].
HJORTH, S ;
CLARK, D ;
CARLSSON, A .
LIFE SCIENCES, 1985, 37 (07) :673-684